NHL: Oilers sign F Colton Sceviour to one-year contract


Share post:

The Edmonton Oilers signed Colton Sceviour and put fellow forward Josh Archibald on long-term injured reserve Wednesday.

The team also placed forward Zack Kassian on injured reserve and recalled forward Kyle Turris from Bakersfield of the American Hockey League in a series of moves ahead of Wednesday night’s season opener against the visiting Vancouver Canucks.

Sceviour made the roster after signing a professional tryout deal in September. He tallied three assists in seven preseason games.

He signed a one-year, two-way contract valued at $750,000.

Sceviour, 32, has 151 points (64 goals, 87 assists) in 500 games over 10 seasons with the Dallas Stars (2011-16), Florida Panthers (2016-20) and Pittsburgh Penguins (2020-21).

Archibald, 29, is dealing with myocarditis after a bout with COVID-19. He has collected 70 points (39 goals, 31 assists) in 235 games with the Penguins (2016-17), Arizona Coyotes (2017-19) and Oilers.

Kassian, 30, has been in the NHL’s concussion protocol since hitting his head on the ice during a fight with Canucks forward Zack MacEwen in a preseason game last Thursday.

Kassian enters his 11th season with 182 points (84 goals, 98 assists) in 552 games with the Buffalo Sabres (2011-12), Canucks (2012-15) and Oilers.

–Field Level Media


Related articles

NHL: Reports: Patrick Kane to join Red Wings

Patrick Kane plans to resume his career with the Detroit Red Wings, according to multiple reports on Tuesday. ESPN...

NHL: Resurgent Oilers set for big test vs. Golden Knights

After back-to-back wins during which they scored a combined 13 goals, the Edmonton Oilers may finally have turned...

NHL: Coyotes carry momentum into matchup with Lightning

Riding high after one of their best wins of the season, the Arizona Coyotes will look to keep...

NHL: Maple Leafs glad to be home to oppose Panthers

The Toronto Maple Leafs hope that their first home game in more than two weeks will mean a...


Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.